Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Amy E. Chang"'
Autor:
Amy E. Chang, Gary N. Mann, Benjamin Hoch, Elizabeth T. Loggers, Seth M. Pollack, Orpheus Kolokythas, Robin L. Jones
Publikováno v:
Rare Tumors, Vol 5, Iss 3, Pp e51-e51 (2013)
Gastrointestinal stromal tumors are the most common mesenchymal tumors of the gastrointestinal tract. The introduction of a number of small molecule tyrosine kinase inhibitors has revolutionized the management of metastatic disease. Surgery is the ma
Externí odkaz:
https://doaj.org/article/b92ec0ffde284aa893a778715b5b21de
Autor:
Amy E. Chang, Vaibhav Sahai, Timothy S. Pardee, Muhammad Shaalan Beg, Oxana V. Crysler, Kent A. Griffith, Mark M. Zalupski, Sanjeev Luther, David Bing Zhen
Publikováno v:
Journal of Clinical Oncology. 39:TPS4158-TPS4158
TPS4158 Background: Patients (pts) with advanced biliary tract cancers (BTC) have poor prognosis despite systemic chemotherapy. Gemcitabine and cisplatin is a standard first-line systemic therapy with an overall response rate (ORR) of 26% and a media
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8c0e413e0b7621d649c83748ffd3e31e
https://doi.org/10.1200/jco.2021.39.15_suppl.tps4158
https://doi.org/10.1200/jco.2021.39.15_suppl.tps4158
Autor:
Brenda F. Kurland, Vijayakrishna K. Gadi, Lupe G. Salazar, Isaac C. Jenkins, Qian V. Wu, Hannah M. Linden, Jennifer M. Specht, Julie R. Gralow, Amy E. Chang
Publikováno v:
Clinical breast cancer. 18(1)
Introduction Doxorubicin in combination with cyclophosphamide is active in breast cancer; however, its use in metastatic cancer is limited owing to cardiotoxicity. Pegylated liposomal doxorubicin (PLD) was formulated to decrease the toxicity of conve
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4a5e20e04ce389b53dc2fe9251a8f699
https://pubmed.ncbi.nlm.nih.gov/29174203
https://pubmed.ncbi.nlm.nih.gov/29174203
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 98:E18
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c8dd408bc5474f878107f5aded1b34c2
https://doi.org/10.1016/j.ijrobp.2017.02.107
https://doi.org/10.1016/j.ijrobp.2017.02.107
Autor:
Mary W. Redman, Hannah H Lee, Kinsey A. McCormick, Safi Shahda, Colin C. Pritchard, Vijayakrishna K. Gadi, Bert H. O'Neil, Reina Hibbert, Stacey A. Cohen, Anne Younger, Andrew L. Coveler, William P. Harris, Amy E. Chang, E. Gabriela Chiorean
Publikováno v:
Journal of Clinical Oncology. 35:TPS515-TPS515
TPS515 Background: The epidermal growth factor receptor (EGFR)/HER2 pathway is overactive in several solid tumors, including gastroesophageal, hepatic, colorectal, and pancreatico-biliary cancers. Afatinib is an irreversible inhibitor of the Erb fami
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ee22c3e0046586d82c8298ba2321def7
https://doi.org/10.1200/jco.2017.35.4_suppl.tps515
https://doi.org/10.1200/jco.2017.35.4_suppl.tps515
Autor:
Xiaoyu Chai, Eve T. Rodler, Neal D. Futran, Amy E. Chang, Kris S. Moe, Seth M. Pollack, Elizabeth T. Loggers, Jasjit K. Dillon, Robin L. Jones, Upendra Parvathaneni
Publikováno v:
Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery. 151(6)
To evaluate the treatment, outcome, and prognostic factors in patients with head and neck sarcomas treated in an academic medical center.Case series.Academic medical center.We performed a retrospective analysis of adult patients (n = 97) with primary
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b24b0018758a2c931d3fac8bf38b333e
https://pubmed.ncbi.nlm.nih.gov/25257906
https://pubmed.ncbi.nlm.nih.gov/25257906
Autor:
Yi Yang, Hailing Lu, Cynthia A. Wenner, Ekram Gad, Mark R. Martzen, Amy E. Chang, Leanna J. Standish, Mary L. Disis, Emily R. Larson, Yushe Dang
Purpose: Polysaccharide krestin (PSK) is a mushroom extract that has been long used in Asia and recently in Western countries as a treatment for cancer due to its presumed immune potentiating effects. Although there have been reports of clinical resp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::90e0d4bdcce64489a25aa1b055d67d1e
https://europepmc.org/articles/PMC3017241/
https://europepmc.org/articles/PMC3017241/
Autor:
Mary L. Disis, Emily R. Larson, Helena Tufvesson, Lynn M. Amon, Hangjun Duan, Yi Yang, Nathaniel Van Denend, Amy E. Chang, Hailing Lu, Wolfgang Wagner, Ekram Gad
Publikováno v:
Journal of immunology (Baltimore, Md. : 1950). 184(9)
Multiple TLR agonists have been shown to have antitumor effects in animal models. However, the therapeutic efficacy of TLR agonist monotherapy in cancer treatment has been limited, and the mechanisms of failure remain unknown. We demonstrate that top
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::548ad3513dd2c41d1fd8e25436cab8da
https://pubmed.ncbi.nlm.nih.gov/20308630
https://pubmed.ncbi.nlm.nih.gov/20308630
Autor:
Gary N. Mann, Orpheus Kolokythas, Elizabeth T. Loggers, Seth M. Pollack, Amy E. Chang, Benjamin Hoch, Robin L. Jones
Publikováno v:
Rare Tumors
Rare Tumors, Vol 5, Iss 3, Pp e51-e51 (2013)
Rare Tumors, Vol 5, Iss 3, Pp e51-e51 (2013)
Gastrointestinal stromal tumors are the most common mesenchymal tumors of the gastrointestinal tract. The introduction of a number of small molecule tyrosine kinase inhibitors has revolutionized the management of metastatic disease. Surgery is the ma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dd70956bcab26d2d696edffbeeeba67e
https://doi.org/10.4081/rt.2013.e51
https://doi.org/10.4081/rt.2013.e51